FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

3601511000001100: Azelastine 140micrograms/actuation nasal spray 20 ml (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22315301000001113 Azelastine 140micrograms/actuation nasal spray 20 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58716501000001114 Azelastine 140micrograms/dose nasal spray 20 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


6 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azelastine 140micrograms/actuation nasal spray 20 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Azelastine 140micrograms/actuation nasal spray 20 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Azelastine 140micrograms/actuation nasal spray 20 ml Is pack of Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) false Inferred relationship Existential restriction modifier
Azelastine 140micrograms/actuation nasal spray 20 ml Has active ingredient Azelastine hydrochloride false Inferred relationship Existential restriction modifier
Azelastine 140micrograms/actuation nasal spray 20 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Azelastine 140micrograms/actuation nasal spray 20 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Azelastine 140micrograms/actuation nasal spray 20 ml Has manufactured dose form Spray dose form false Inferred relationship Existential restriction modifier
Azelastine 140micrograms/actuation nasal spray 20 ml Has VMP Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) true Inferred relationship Existential restriction modifier
Azelastine 140micrograms/actuation nasal spray 20 ml Has specific active ingredient Azelastine hydrochloride true Inferred relationship Existential restriction modifier
Azelastine 140micrograms/actuation nasal spray 20 ml Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Rhinolast 140micrograms/dose nasal spray (Viatris UK Healthcare Ltd) 20 ml Is a True Azelastine 140micrograms/actuation nasal spray 20 ml Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (PI) (Waymade Ltd) 20 ml Is a True Azelastine 140micrograms/actuation nasal spray 20 ml Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (PI) (Dowelhurst Ltd) 20 ml Is a True Azelastine 140micrograms/actuation nasal spray 20 ml Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Doncaster Pharmaceuticals Ltd) 20 ml Is a True Azelastine 140micrograms/actuation nasal spray 20 ml Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/actuation nasal spray (Sigma Pharmaceuticals Plc) 20 ml Is a True Azelastine 140micrograms/actuation nasal spray 20 ml Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml Is a True Azelastine 140micrograms/actuation nasal spray 20 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start